The global urinalysis market size is expected to reach USD 6.85 billion by 2030, expanding at a CAGR of 7.83% from 2025 to 2030. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).
Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.
Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.
Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.
This product will be delivered within 1-3 business days.
Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.
Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.
Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.
Urinalysis Market Report Highlights
- The consumables segment held the dominant revenue share of 78.56% in terms of revenue in 2024. This dominance can be attributed to the increasing demand and frequent purchases of reagents and dipsticks by clinical and hospital laboratories.
- The urinary tract infection screening segment dominated the market and accounted for a revenue share of 24.07% in 2024, due to the rising incidence of UTIs worldwide.
- The clinical laboratories segment accounted for the highest revenue share of around 45.88% in 2024. This can be attributed to their easy accessibility to patients and the availability of advanced products in these laboratories.
- North America urinalysis market dominated the market and accounted for the largest revenue share of 37.9% in 2024.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Urinalysis Market Variables, Trends & Scope
Chapter 4. Urinalysis Market: Product Estimates & Trend Analysis
Chapter 5. Urinalysis Market: Application Estimates & Trend Analysis
Chapter 6. Urinalysis Market: End Use Estimates & Trend Analysis
Chapter 7. Urinalysis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Abbott
- Sysmex Corporation
- Siemens Healthineers AG
- ACON Laboratories, Inc.
- ARKRAY Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | January 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 4.37 Billion |
| Forecasted Market Value ( USD | $ 6.85 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
